Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
For a more detailed research summary, see our AOD-9604 fat loss research guide and our AOD-9604 vs Retatrutide comparison
By mimicking natural GLP-1 hormone activity, it not only lowers blood glucose but also curbs appetite and promotes cardiovascular health
Instead, GIP co-activation seems to buffer some of the harsher GLP-1 effects
Second, and just as important, the benefit reversed when the drug was stopped visceral fat re-accumulated after discontinuation
In December 2024, the FDA approved Zepbound (tirzepatide) for moderate-to-severe obstructive sleep apnea in adults with obesity, used alongside a reduced-calorie diet and more physical activity
